Trial Profile
(Val)Ganciclovir Therapeutic Drug Monitoring in Transplant Recipients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2021
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary) ; Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 08 Oct 2019 Planned End Date changed from 31 Jul 2019 to 31 Dec 2019.
- 08 Oct 2019 Planned primary completion date changed from 31 Jul 2019 to 30 Nov 2019.
- 16 Oct 2018 New trial record